Inland Peptides
Inland Peptides

Gonadorelin

Research Snapshot Last reviewed October 2026
Limited

Approved by the FDA for human use

Yes

Studied in human clinical trials

Yes

Published human research

Yes

Published animal research

Primary research areas
  • Reproductive hormone deficiency and fertility

View in catalog →

Overview

Gonadorelin is a synthetic version of gonadotropin-releasing hormone, the brain’s signal to the pituitary gland to release reproductive hormones. Researchers and clinicians have used it to test hormone function and treat certain causes of infertility.

Human medicines containing gonadorelin were sold as Factrel and Lutrepulse in the United States. Those products are discontinued. Separate veterinary products are used in cattle.

What is it being studied for?

Research includes congenital hypogonadotropic hypogonadism, a condition in which missing or weak hormone signals disrupt sexual development and fertility.

Gonadorelin stimulates the pituitary gland to release luteinizing hormone and follicle-stimulating hormone. These hormones act on the ovaries or testes.

What has research found?

Human studies have tested gonadorelin delivered in pulses by a pump for reproductive hormone deficiency, including a study in male infants.

Veterinary studies examine its use in controlling the timing of ovulation in dairy cattle.

FDA status and development history

Factrel and the Lutrepulse kit received FDA approval for human use and are now listed as discontinued. Gonadorelin also has separate veterinary approvals.